|Progesterone receptor modulates ERα action in breast cancer|
H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ...
Nature 523 (7560), 313-317, 2015
|Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer|
BIG 1-98 Collaborative Group
New England Journal of Medicine 361 (8), 766-776, 2009
|Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial|
J Cuzick, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, JF Forbes
The lancet oncology 16 (1), 67-75, 2015
|Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical …|
MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ...
The lancet oncology 12 (12), 1101-1108, 2011
|Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer|
AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ...
Cancer research 69 (15), 6131-6140, 2009
|Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International …|
G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ...
Journal of clinical oncology 26 (34), 5569, 2008
|Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience|
G Berclaz, S Li, KN Price, AS Coates, M Castiglione-Gertsch, ...
Annals of Oncology 15 (6), 875-884, 2004
|Androgens induce divergent proliferative responses in human breast cancer cell lines|
SN Birrell, JM Bentel, TE Hickey, C Ricciardelli, MA Weger, DJ Horsfall, ...
The Journal of steroid biochemistry and molecular biology 52 (5), 459-467, 1995
|Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII|
A Wallgren, M Bonetti, RD Gelber, A Goldhirsch, M Castiglione-Gertsch, ...
Journal of Clinical Oncology 21 (7), 1205-1213, 2003
|Breast and prostate cancer: more similar than different|
GP Risbridger, ID Davis, SN Birrell, WD Tilley
Nature Reviews Cancer 10 (3), 205-212, 2010
|Role of the androgen receptor in human breast cancer|
SN Birrell, RE Hall, WD Tilley
Journal of mammary gland biology and neoplasia 3, 95-103, 1998
|The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer|
TE Hickey, LA Selth, KM Chia, G Laven-Law, HH Milioli, D Roden, ...
Nature medicine 27 (2), 310-320, 2021
|Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells|
JM Bentel, SN Birrell, MA Pickering, DJ Holds, DJ Horsfall, WD Tilley
Molecular and cellular endocrinology 154 (1-2), 11-20, 1999
|Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer|
SN Birrell, LM Butler, JM Harris, G Buchanan, WD Tilley
The FASEB Journal 21 (10), 2285-2293, 2007
|MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression|
RE Hall, SN Birrell, WD Tilley, RL Sutherland
European Journal of Cancer 30 (4), 484-490, 1994
|Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer|
RE Hall, JO Aspinall, DJ Horsfall, SN Birrell, JM Bentel, RL Sutherland, ...
British journal of cancer 74 (8), 1175-1180, 1996
|Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors|
EJ Cops, T Bianco-Miotto, NL Moore, CL Clarke, SN Birrell, LM Butler, ...
The Journal of steroid biochemistry and molecular biology 110 (3-5), 236-243, 2008
|Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.|
SN Birrell, DM Roder, DJ Horsfall, JM Bentel, WD Tilley
Journal of clinical oncology 13 (7), 1572-1577, 1995
|A patient‐derived explant (PDE) model of hormone‐dependent cancer|
MM Centenera, TE Hickey, S Jindal, NK Ryan, P Ravindranathan, ...
Molecular oncology 12 (9), 1608-1622, 2018
|Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for …|
MM Regan, KN Price, A Giobbie-Hurder, B Thürlimann, RD Gelber, ...
Breast Cancer Research 13, 1-16, 2011